Cresanto Global Limited (BOM:531207)
5.12
0.00 (0.00%)
At close: Aug 17, 2026
Cresanto Global Revenue
Cresanto Global had revenue of 539.00K INR in the twelve months ending June 30, 2026, down -89.75% year-over-year. In the fiscal year ending March 31, 2026, Cresanto Global had annual revenue of 539.00K.
Revenue
539.00K
Revenue Growth
-89.75%
P/S Ratio
40.59
Revenue / Employee
107.80K
Employees
5
Market Cap
21.88M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 539.00K | - | - |
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | 206.32K | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vivanza Biosciences | 1.17B |
| Beryl Drugs | 215.51M |
| Fabino Enterprises | 208.41M |
| Brawn Biotech | 173.07M |
| Unjha Formulations | 152.79M |
| Decipher Labs | 138.51M |
| Ganga Pharmaceuticals | 28.28M |
| Emmessar Biotech & Nutrition | 23.78M |